Cure JM Medical Conference:
2017 Update on Juvenile Myositis Care and Research

(6 AMA PRA Category 1 Credits™ for Main Program and 1 AMA PRA Category 1 Credits™ for Pre-Program)

Open to physicians and the medical community with a special focus on those in pediatrics, rheumatology, dermatology, and neurology.

This CME activity, including meals, is FREE, but registration is required.

Eventbrite - 2017 Update on Juvenile Myositis Care and Research  - 6 AMA PRA Category 1 Credits™

Dell  Children's Medical Center of Central TexasDate and Time

Friday, February 17th, 2017
Pre Program: 7:15am – 8:30am
Main Program: 8:30am – 4:30pm


Dell  Children's Medical Center of Central TexasDell Children’s Medical Center (DCMC) Main Auditorium
4900 Mueller Blvd
Austin, TX 78723

Learning Objectives

  1. Identify best practices in diagnosing and treating patients with Juvenile Myositis (JM).
  2. Identify how metabolomics, proteomics, and genomics can lead to better individualized care.
  3. Identify how to improve patient satisfaction, gain patient loyalty, and smooth transition to adult care.
  4. Discuss selected JM case studies and make consensus treatment plans to optimize care.


Pre Program




Grand Rounds – Overview of Juvenile Myositis in 2017

Ann Reed, MD, Chair, Department of Pediatrics, Duke University School of Medicine

Main Program


Welcome and Conference Overview

Steven Abrams, MD, Chair of Pediatrics, Dell Medical School; Director, Dell Pediatric Research Institute

Mitali Dave, President, Cure JM Foundation


Labs, Imaging, and What they Mean in Juvenile Myositis

Adam Huber, MD, Staff Pediatric Rheumatologist, IWK Health Centre, Halifax, Nova Scotia




Skin Signs of Rheumatological Disorders including Juvenile Myositis

Moise Levy, MD, Physician-in-Chief, DCMC; Chief, Pediatric Dermatology, DCMC


Non-Biologic Treatment of Juvenile Myositis: 2017 Update

Lauren M. Pachman MD, Professor of Pediatrics, Northwestern University Feinberg School of Medicine; Director, Cure JM Program of Excellence in JM Care and Research


Emerging Applications of Metabolomics in Precision Medicine

Stefano Tiziani, PhD, Assistant Professor, UT Austin


Lunch and Remarks from Dell Children’s Medical Center

Mark Shen, MD, President, DCMC


Potential New Treatments with Biologics and Drug Therapies for Juvenile Myositis

Lisa Rider, MD, Deputy Chief, Environmental Autoimmunity Group, National Institute of Environmental Health Sciences, National Institutes of Health


Transitioning from Pediatrics to an Adult Medical Home

Ankur Kamdar, MD, Assistant Professor of Pediatrics, UT Health Houston




Patient - Provider Experience

Ruy Carrasco, MD, Division Chief, Rheumatology, DCMC


Case Studies

Kaveh Ardalan, MD, Lurie Children's Hospital of Chicago, Colleen Correll, MD, University of Minnesota, and Megan Curran, MD, Lurie Children's Hospital of Chicago


Wrap Up and Close


You are also welcome to attend the Cure JM Family Conference at nearby Lakeway Resort & Spa from February 17th to February 19th, 2017.

If you are only attending the Medical Conference — and not the Family Conference — we recommend staying two blocks away at Residence Inn - Austin University Area. Ask for the Dell Children's / Seton rate.

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Texas Medical Association (TMA) through the joint providership of Seton Healthcare Family and Cure JM Foundation.

The Seton Healthcare Family is accredited by the Texas Medical Association to provide continuing medical education for physicians.

The Seton Healthcare Family designates this live activity for a maximum of 6 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Contact or

Eventbrite - 2017 Update on Juvenile Myositis Care and Research - 6 AMA PRA Category 1 Credits